KALV - Kalvista Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALV is currently covered by 5 analysts with an average price target of $34.14. This is a potential upside of $7.14 (26.44%) from yesterday's end of day stock price of $27.

Kalvista Pharmaceuticals's activity chart (see below) currently has 106 price targets and 98 ratings on display. The stock rating distribution of KALV is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.82% with an average time for these price targets to be met of 410.09 days.

Highest price target for KALV is $42, Lowest price target is $27, average price target is $34.14.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 01-May-2026. First documented stock forecast 04-May-2015.

Currently out of the existing stock ratings of KALV, 10 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Jun-2020

$27

$37

5 months 7 days ago
(01-May-2026)

14/16 (87.5%)

$0.35 (1.31%)

423

Buy Since 20-Mar-2019

$35

5 months 8 days ago
(30-Apr-2026)

5/25 (20%)

$18.2 (108.33%)

677

Buy Since 15-Oct-2018

$42

$15 (55.56%)

$39

6 months 12 days ago
(26-Mar-2026)

2/8 (25%)

$23.05 (121.64%)

670

Buy Since 31-Jan-2025

$28

$1 (3.70%)

$28

6 months 12 days ago
(26-Mar-2026)

5/8 (62.5%)

$9.05 (47.76%)

369

Buy Since 07-Jan-2025

$35

$8 (29.63%)

$30

8 months 6 days ago
(02-Feb-2026)

0/2 (0%)

$18.89 (117.26%)

Show more analysts

Please expand the browser size to see the chart

What is KALV (Kalvista Pharmaceuticals) average time for price targets to be met?

On average it took 410 days for the stock forecasts to be reached, with an average price target met ratio of 48.82%.

Which analyst most recently updated their price target on KALV (Kalvista Pharmaceuticals)?

Andrew Fein

Which analyst has the most public recommendations on KALV (Kalvista Pharmaceuticals)?

Andrew Fein works at HC WAINWRIGHT and has 29 price targets and 22 ratings on KALV

Which analyst is the currently most bullish on KALV (Kalvista Pharmaceuticals)?

Jason Gerberry with the highest potential upside of $207

Which analyst is the currently most reserved on KALV (Kalvista Pharmaceuticals)?

Joseph Schwartz with the lowest potential downside of -$7
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?